Evaluation of a Lyme disease enzyme immunoassay using the 41-G fragment of flagellin

Eur J Clin Microbiol Infect Dis. 1995 Jul;14(7):609-13. doi: 10.1007/BF01690736.

Abstract

An immunogenic region of the Borrelia burgdorferi flagellin encompassing amino acids 197-273 and designated 41-G was evaluated as an antigen in an enzyme immunoassay (EIA) for Lyme disease on a routine basis in a reference laboratory. Sera that tested positive for Lyme disease by EIA using 41-G or the whole-cell Borrelia burgdorferi lysate as the antigen were also evaluated by immunoblot for reactivity with Borrelia burgdorferi, and the patient's clinical history was determined retrospectively by a questionnaire distributed to the referring physician. The sensitivity of the 41-G based EIA for the serologic diagnosis of Lyme disease, when compared with that of the Borrelia burgdorferi lysate EIA, was 70% (35 of 50). These data demonstrate that 41-G has utility as an antigen in EIA, although the sensitivity is at present less than that of the assay employing the Borrelia burgdorferi whole-cell lysate.

Publication types

  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Antigens, Bacterial / immunology*
  • Borrelia burgdorferi Group / immunology*
  • Flagellin / immunology*
  • Humans
  • Immunoenzyme Techniques
  • Lyme Disease / diagnosis*
  • Peptide Fragments / immunology*
  • Serologic Tests

Substances

  • Antigens, Bacterial
  • Peptide Fragments
  • Flagellin